{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:10:03Z","timestamp":1790878203139,"version":"4.1.0"},"reference-count":99,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>In recent years evidence has emerged that neurodegenerative diseases (NDs) are strongly associated with the microbiome composition in the gut. Parkinson\u2019s disease (PD) is the most intensively studied neurodegenerative disease in this context. In this review, we performed a systematic evaluation of the published literature comparing changes in colonic microbiome in PD to the ones observed in other NDs including Alzheimer\u2019s disease (AD), multiple system atrophy (MSA), multiple sclerosis (MS), neuromyelitis optica (NMO) and amyotrophic lateral sclerosis (ALS). To enhance the comparability of different studies, only human case-control studies were included. Several studies showed an increase of Lactobacillus, Bifidobacterium, Verrucomicrobiaceae and Akkermansia in PD. A decrease of Faecalibacterium spp., Coprococcus spp., Blautia spp., Prevotella spp. and Prevotellaceae was observed in PD. On a low taxonomic resolution, like the phylum level, the changes are not disease-specific and are inconsistent. However, on a higher taxonomic resolution like genus or species level, a minor overlap was observed between PD and MSA, both alpha synucleinopathies. We show that standardization of sample collection and analysis is necessary for ensuring the reproducibility and comparability of data. We also provide evidence that assessing the microbiota composition at high taxonomic resolution reveals changes in relative abundance that may be specific to or characteristic of one disease or disease group, and might evolve discriminative power. The interactions between bacterial species and strains and the co-abundances must be investigated before assumptions about the effects of specific bacteria on the host can be made with certainty.<\/jats:p>","DOI":"10.3390\/nu10060708","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T03:02:50Z","timestamp":1527822170000},"page":"708","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":219,"title":["Changes of Colonic Bacterial Composition in Parkinson\u2019s Disease and Other Neurodegenerative Diseases"],"prefix":"10.3390","volume":"10","author":[{"given":"Sara","family":"Gerhardt","sequence":"first","affiliation":[{"name":"Departement of human medicine, University of Zurich, Winterthurerstrasse 190, 8057 Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2112-6281","authenticated-orcid":false,"given":"M. Hasan","family":"Mohajeri","sequence":"additional","affiliation":[{"name":"Departement of human medicine, University of Zurich, Winterthurerstrasse 190, 8057 Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2009.08.007","article-title":"A timeline for parkinson\u2019s disease","volume":"16","author":"Hawkes","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrneurol.2015.197","article-title":"Pathogenesis of parkinson disease\u2014The gut-brain axis and environmental factors","volume":"11","author":"Klingelhoefer","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Idiopathic parkinson\u2019s disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"2003","journal-title":"J. Neural. Transm. (Vienna)"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-017-1777-8","article-title":"Does parkinson\u2019s disease start in the gut?","volume":"135","author":"Lionnet","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s40473-017-0129-2","article-title":"Microbes tickling your tummy: The importance of the gut-brain axis in parkinson\u2019s disease","volume":"4","author":"Hartog","year":"2017","journal-title":"Curr. Behav. Neurosci. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cell.2016.01.013","article-title":"Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans","volume":"164","author":"Sender","year":"2016","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13311-017-0598-8","article-title":"Microbiota signaling pathways that influence neurologic disease","volume":"15","author":"Cox","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/B978-0-12-382026-6.00040-3","article-title":"Gastrointestinal microbial ecology with perspectives on health and disease","volume":"1","author":"Gillilland","year":"2012","journal-title":"Physiol. Gastrointest. Tract."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.copbio.2012.08.005","article-title":"Bacteria as vitamin suppliers to their host: A gut microbiota perspective","volume":"24","author":"LeBlanc","year":"2013","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/gmic.19320","article-title":"The role of gut microbiota in immune homeostasis and autoimmunity","volume":"3","author":"Wu","year":"2012","journal-title":"Gut. Microbes"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hug, H., Mohajeri, M.H., and La Fata, G. (2018). Toll-like receptors: Regulators of the immune response in the human gut. Nutrients, 10.","DOI":"10.3390\/nu10020203"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12602-017-9322-6","article-title":"Probiotics and the gut immune system: Indirect regulation","volume":"10","author":"Weber","year":"2018","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1172\/JCI58109","article-title":"Gut microbiome, obesity, and metabolic dysfunction","volume":"121","author":"Tilg","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.tim.2016.08.001","article-title":"Health disparities and the microbiome","volume":"24","author":"Findley","year":"2016","journal-title":"Trends Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.cub.2016.04.016","article-title":"Gut microbiota and extreme longevity","volume":"26","author":"Biagi","year":"2016","journal-title":"Curr. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"902","DOI":"10.18632\/aging.100623","article-title":"Functional metagenomic profiling of intestinal microbiome in extreme ageing","volume":"5","author":"Rampelli","year":"2013","journal-title":"Aging (Albany NY)"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","article-title":"Brain-gut-microbiota axis in parkinson\u2019s disease","volume":"21","author":"Mulak","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","article-title":"Direct evidence of parkinson pathology spread from the gastrointestinal tract to the brain in rats","volume":"128","author":"Holmqvist","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1212\/WNL.0000000000003961","article-title":"Vagotomy and parkinson disease","volume":"88","author":"Liu","year":"2017","journal-title":"Neurology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/mds.25979","article-title":"Enteric glial cells: New players in parkinson\u2019s disease?","volume":"30","author":"Clairembault","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clinthera.2016.12.014","article-title":"Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis","volume":"39","author":"Zhang","year":"2017","journal-title":"Clin. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e12356","DOI":"10.14814\/phy2.12356","article-title":"Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model","volume":"3","author":"Wu","year":"2015","journal-title":"Physiol. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"41802","DOI":"10.1038\/srep41802","article-title":"Reduction of abeta amyloid pathology in appps1 transgenic mice in the absence of gut microbiota","volume":"7","author":"Harach","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Mohajeri, M.H., La Fata, G., Steinert, R.E., and Weber, P. (2018). Relationship between the gut microbiome and brain function. Nutr. Rev.","DOI":"10.1093\/nutrit\/nuy009"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Di Meo, F., Donato, S., Di Pardo, A., Maglione, V., Filosa, S., and Crispi, S. (2018). New therapeutic drugs from bioactive natural molecules: The role of gut microbiota metabolism in neurodegenerative diseases. Curr. Drug. Metab.","DOI":"10.2174\/1389200219666180404094147"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2017.10.379","article-title":"Aging and parkinson\u2019s disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis","volume":"115","author":"Calabrese","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.02.002","article-title":"Gut microbiota: Implications in parkinson\u2019s disease","volume":"38","author":"Parashar","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2016.03.012","article-title":"Microbiota-gut-brain signalling in parkinson\u2019s disease: Implications for non-motor symptoms","volume":"27","author":"Felice","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/mds.27197","article-title":"The prodromal microbiome","volume":"33","author":"Scheperjans","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3233\/JPD-150557","article-title":"Linking smoking, coffee, urate, and parkinson's disease\u2014A role for gut microbiota?","volume":"5","author":"Scheperjans","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The prisma statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s10517-017-3700-7","article-title":"Analysis of gut microbiota in patients with parkinson\u2019s disease","volume":"162","author":"Petrov","year":"2017","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mds.26942","article-title":"Parkinson\u2019s disease and parkinson\u2019s disease medications have distinct signatures of the gut microbiome","volume":"32","author":"Debelius","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2017.04.019","article-title":"Gut microbiota in parkinson disease in a northern german cohort","volume":"1667","author":"Hopfner","year":"2017","journal-title":"Brain Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s11427-016-9001-4","article-title":"Structural changes of gut microbiota in parkinson\u2019s disease and its correlation with clinical features","volume":"60","author":"Li","year":"2017","journal-title":"Sci. China Life Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/mds.26307","article-title":"Colonic bacterial composition in parkinson\u2019s disease","volume":"30","author":"Keshavarzian","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13073-017-0428-y","article-title":"Functional implications of microbial and viral gut metagenome changes in early stage l-dopa-na\u00efve parkinson\u2019s disease patients","volume":"9","author":"Bedarf","year":"2017","journal-title":"Genome Med."},{"key":"ref_40","first-page":"88","article-title":"The nasal and gut microbiome in parkinson\u2019s disease and idiopathic rapid eye movement sleep behavior disorder","volume":"33","author":"Pandey","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to parkinson\u2019s disease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Hasegawa, S., Goto, S., Tsuji, H., Okuno, T., Asahara, T., Nomoto, K., Shibata, A., Fujisawa, Y., Minato, T., and Okamoto, A. (2015). Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in parkinson\u2019s disease. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0142164"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","article-title":"Short chain fatty acids and gut microbiota differ between patients with parkinson\u2019s disease and age-matched controls","volume":"32","author":"Unger","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Mariat, D., Firmesse, O., Levenez, F., Guimaraes, V., Sokol, H., Dore, J., Corthier, G., and Furet, J.P. (2009). The firmicutes\/bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol., 9.","DOI":"10.1186\/1471-2180-9-123"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3389\/fmicb.2016.01479","article-title":"Evaluation of the microbial diversity in amyotrophic lateral sclerosis using high-throughput sequencing","volume":"7","author":"Fang","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.14814\/phy2.13443","article-title":"Gut inflammation and dysbiosis in human motor neuron disease","volume":"5","author":"Rowin","year":"2017","journal-title":"Physiol. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3233\/JPD-160991","article-title":"The potential role of gut-derived inflammation in multiple system atrophy","volume":"7","author":"Engen","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"ref_48","first-page":"501","article-title":"Frequency of firmicutes and bacteroidetes in gut microbiota in obese and normal weight egyptian children and adults","volume":"7","author":"Ragab","year":"2011","journal-title":"Arch. Med. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Koliada, A., Syzenko, G., Moseiko, V., Budovska, L., Puchkov, K., Perederiy, V., Gavalko, Y., Dorofeyev, A., Romanenko, M., and Tkach, S. (2017). Association between body mass index and firmicutes\/bacteroidetes ratio in an adult ukrainian population. BMC Microbiol., 17.","DOI":"10.1186\/s12866-017-1027-1"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/oby.2009.167","article-title":"Microbiota and scfa in lean and overweight healthy subjects","volume":"18","author":"Schwiertz","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11130-016-0542-9","article-title":"Dextrins from maize starch as substances activating the growth of bacteroidetes and actinobacteria simultaneously inhibiting the growth of firmicutes, responsible for the occurrence of obesity","volume":"71","author":"Barczynska","year":"2016","journal-title":"Plant. Foods Hum. Nutr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/ijo.2008.155","article-title":"Human colonic microbiota associated with diet, obesity and weight loss","volume":"32","author":"Duncan","year":"2008","journal-title":"Int J. Obes."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1574-6968.2012.02523.x","article-title":"Freezing fecal samples prior to dna extraction affects the firmicutes to bacteroidetes ratio determined by downstream quantitative pcr analysis","volume":"329","author":"Walsh","year":"2012","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mimet.2016.08.005","article-title":"Bead-beating artefacts in the bacteroidetes to firmicutes ratio of the human stool metagenome","volume":"129","author":"Vebo","year":"2016","journal-title":"J. Microbiol. Methods"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Vogt, N.M., Kerby, R.L., Dill-McFarland, K.A., Harding, S.J., Merluzzi, A.P., Johnson, S.C., Carlsson, C.M., Asthana, S., Zetterberg, H., and Blennow, K. (2017). Gut microbiome alterations in alzheimer\u2019s disease. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-13601-y"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Miyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., Chihara, N., Tomita, A., Sato, W., and Kim, S.W. (2015). Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia xiva and iv clusters. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0137429"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ana.24718","article-title":"Gut microbiome analysis in neuromyelitis optica reveals overabundance of clostridium perfringens","volume":"80","author":"Cree","year":"2016","journal-title":"Ann. Neurol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.23651","article-title":"Aquaporin 4-specific t cells in neuromyelitis optica exhibit a th17 bias and recognize clostridium abc transporter","volume":"72","author":"Spencer","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s13311-017-0594-z","article-title":"The gut microbiome in neuromyelitis optica","volume":"15","author":"Zamvil","year":"2017","journal-title":"Neurotherapeutics"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.anaerobe.2016.06.006","article-title":"New insights into clostridium perfringens epsilon toxin activation and action on the brain during enterotoxemia","volume":"41","author":"Freedman","year":"2016","journal-title":"Anaerobe"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.toxicon.2017.02.019","article-title":"Clostridium perfringens epsilon toxin induces permanent neuronal degeneration and behavioral changes","volume":"130","author":"Morris","year":"2017","journal-title":"Toxicon"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e02513","DOI":"10.1128\/mBio.02513-14","article-title":"Clostridium perfringens epsilon toxin causes selective death of mature oligodendrocytes and central nervous system demyelination","volume":"6","author":"Linden","year":"2015","journal-title":"MBio"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"12015","DOI":"10.1038\/ncomms12015","article-title":"Alterations of the human gut microbiome in multiple sclerosis","volume":"7","author":"Jangi","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/JIM.0000000000000192","article-title":"Gut microbiota in multiple sclerosis: Possible influence of immunomodulators","volume":"63","author":"Cantarel","year":"2015","journal-title":"J. Investig. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"28484","DOI":"10.1038\/srep28484","article-title":"Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/ene.13026","article-title":"Gut microbiota in early pediatric multiple sclerosis: A case-control study","volume":"23","author":"Tremlett","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Cases, M., Llobet, A., Terni, B., Gomez de Aranda, I., Blanch, M., Doohan, B., Revill, A., Brown, A.M., Blasi, J., and Solsona, C. (2017). Acute effect of pore-forming clostridium perfringens epsilon-toxin on compound action potentials of optic nerve of mouse. eNeuro, 4.","DOI":"10.1523\/ENEURO.0051-17.2017"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"24162","DOI":"10.1038\/srep24162","article-title":"Immunization with a novel clostridium perfringens epsilon toxin mutant retx(y196e)-c confers strong protection in mice","volume":"6","author":"Yao","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/mds.27203","article-title":"Altered gut microbiome and metabolome in patients with multiple system atrophy","volume":"33","author":"Tan","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neurobiolaging.2017.09.023","article-title":"The fecal microbiome of als patients","volume":"61","author":"Brenner","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1572-0241.2005.40312.x","article-title":"Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time pcr","volume":"100","author":"Malinen","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"138","DOI":"10.7224\/1537-2073.2015-020","article-title":"Safety and tolerability of delayed-release dimethyl fumarate administered with interferon beta or glatiramer acetate in relapsing-remitting multiple sclerosis","volume":"18","author":"Calkwood","year":"2016","journal-title":"Int. J. MS Care"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Wicks, P., Rasouliyan, L., Katic, B., Nafees, B., Flood, E., and Sasan\u00e9, R. (2016). The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis. BMC Res Notes, 9.","DOI":"10.1186\/s13104-016-2243-8"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"14057","DOI":"10.1523\/JNEUROSCI.3890-09.2009","article-title":"Ghrelin promotes and protects nigrostriatal dopamine function via a ucp2-dependent mitochondrial mechanism","volume":"29","author":"Andrews","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3109\/00207454.2015.1096271","article-title":"Potential role of gut microbiota and tissue barriers in parkinson\u2019s disease and amyotrophic lateral sclerosis","volume":"126","author":"Fang","year":"2016","journal-title":"Int. J. Neurosci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3389\/fmicb.2017.01226","article-title":"Functional characterization of novel faecalibacterium prausnitzii strains isolated from healthy volunteers: A step forward in the use of f. Prausnitzii as a next-generation probiotic","volume":"8","author":"Martin","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Maier, E., Anderson, R.C., and Roy, N.C. (2017). Live faecalibacterium prausnitzii does not enhance epithelial barrier integrity in an apical anaerobic co-culture model of the large intestine. Nutrients, 9.","DOI":"10.3390\/nu9121349"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.3389\/fmicb.2017.01790","article-title":"New insights into the diversity of the genus faecalibacterium","volume":"8","author":"Benevides","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2014.09.053","article-title":"Human genetics shape the gut microbiome","volume":"159","author":"Goodrich","year":"2014","journal-title":"Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2016.08.019","article-title":"Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly","volume":"49","author":"Cattaneo","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1074\/jbc.R116.767434","article-title":"Glucuronides in the gut: Sugar-driven symbioses between microbe and host","volume":"292","author":"Pellock","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e01102","DOI":"10.7554\/eLife.01102","article-title":"The human gut and groundwater harbor non-photosynthetic bacteria belonging to a new candidate phylum sibling to cyanobacteria","volume":"2","author":"Sharon","year":"2013","journal-title":"Elife"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"13380","DOI":"10.1073\/pnas.2235808100","article-title":"Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the chamorro people of guam","volume":"100","author":"Cox","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/nutrit\/nuw023","article-title":"Role of gut microbiota and nutrients in amyloid formation and pathogenesis of alzheimer disease","volume":"74","author":"Pistollato","year":"2016","journal-title":"Nutr. Rev."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-0404.2008.01150.x","article-title":"Cyanobacterial neurotoxin bmaa in als and alzheimer\u2019s disease","volume":"120","author":"Pablo","year":"2009","journal-title":"Acta Neurol. Scand."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fncel.2013.00153","article-title":"Alzheimer\u2019s disease and the microbiome","volume":"7","author":"Bhattacharjee","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2174\/1871527313666140228114456","article-title":"Crystal structure and interaction of phycocyanin with \u03b2-secretase: A putative therapy for alzheimer\u2019s disease","volume":"13","author":"Singh","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00709-016-0996-5","article-title":"Phycoerythrin averts intracellular ros generation and physiological functional decline in eukaryotes under oxidative stress","volume":"254","author":"Sonani","year":"2017","journal-title":"Protoplasma"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Minato, T., Maeda, T., Fujisawa, Y., Tsuji, H., Nomoto, K., Ohno, K., and Hirayama, M. (2017). Progression of parkinson\u2019s disease is associated with gut dysbiosis: Two-year follow-up study. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0187307"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/PSY.0000000000000454","article-title":"Social influences on prevotella and the gut microbiome of young monkeys","volume":"79","author":"Amaral","year":"2017","journal-title":"Psychosom. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40168-016-0202-1","article-title":"Unusual sub-genus associations of faecal prevotella and bacteroides with specific dietary patterns","volume":"4","author":"Pellegrini","year":"2016","journal-title":"Microbiome"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.micpath.2016.02.005","article-title":"Akkermansia muciniphila and its role in regulating host functions","volume":"106","author":"Derrien","year":"2017","journal-title":"Microbial. Pathog."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1128\/AEM.01226-07","article-title":"The mucin degrader akkermansia muciniphila is an abundant resident of the human intestinal tract","volume":"74","author":"Derrien","year":"2008","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Forsyth, C.B., Shannon, K.M., Kordower, J.H., Voigt, R.M., Shaikh, M., Jaglin, J.A., Estes, J.D., Dodiya, H.B., and Keshavarzian, A. (2011). Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early parkinson\u2019s disease. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028032"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/mds.25375","article-title":"Pilot study of h(2) therapy in parkinson\u2019s disease: A randomized double-blind placebo-controlled trial","volume":"28","author":"Yoritaka","year":"2013","journal-title":"Mov. Disord."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neulet.2009.02.016","article-title":"Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of parkinson\u2019s disease","volume":"453","author":"Fu","year":"2009","journal-title":"Neurosci. Lett."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/nmeth.2693","article-title":"Metagenomic species profiling using universal phylogenetic marker genes","volume":"10","author":"Sunagawa","year":"2013","journal-title":"Nat. Methods"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/jci.insight.92295","article-title":"\u0391-synuclein in gut endocrine cells and its implications for parkinson\u2019s disease","volume":"2","author":"Chandra","year":"2017","journal-title":"JCI Insight"},{"key":"ref_99","unstructured":"He, Z. (2014). Microarrays, Caister Academic Press."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/10\/6\/708\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:06:47Z","timestamp":1760195207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/10\/6\/708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":99,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["nu10060708"],"URL":"https:\/\/doi.org\/10.3390\/nu10060708","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints201804.0370.v1","asserted-by":"object"}]},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]}}}